Federal award
ABBOTT LABORATORIES INC.
W81K0022P0154
Contract
Obligated and Ceiling
- Obligated (net)
- $1,376,637.91
- Ceiling (potential value, not spending)
- $1,664,718.13
- Current value
- $1,664,718.13
- Gross positive obligations
- $1,640,280.89
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ABBOTT LABORATORIES INC. · NH3LDK8CFAK7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ABBOTT LABORATORIES INC. · L3AXXYLB3V56
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0022P0154
- Award type code
- B
- Actions
- 19 · Jun 24, 2022 to Jun 16, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History19
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 16, 2026 | FY2026 | P00018 | M | $0.00 | — |
| Jun 9, 2026 | FY2026 | P00017 | G | $0.00 | — |
| Apr 1, 2026 | FY2026 | P00016 | C | $37,501.89 | — |
| Mar 26, 2026 | FY2026 | P00015 | M | −$37,502.00 | — |
| Feb 18, 2026 | FY2026 | P00014 | C | −$61,616.00 | — |
| Dec 1, 2025 | FY2026 | P00013 | C | $384,114.00 | — |
| Sep 23, 2025 | FY2025 | P00012 | C | −$121,898.98 | — |
| Jul 28, 2025 | FY2025 | P00011 | C | −$42,626.00 | — |
| May 13, 2025 | FY2025 | P00010 | G | $0.00 | — |
| Dec 10, 2024 | FY2025 | P00009 | C | $384,114.00 | — |
| Aug 1, 2024 | FY2024 | P00008 | G | $0.00 | — |
| Jun 4, 2024 | FY2024 | P00007 | B | $0.00 | — |
| Nov 22, 2023 | FY2024 | P00006 | C | $356,664.00 | — |
| Aug 15, 2023 | FY2023 | P00005 | G | $0.00 | — |
| Jul 18, 2023 | FY2023 | P00004 | B | $36,495.00 | — |
| May 3, 2023 | FY2023 | P00003 | B | $17,752.00 | — |
| Nov 10, 2022 | FY2023 | P00002 | C | $338,912.00 | — |
| Aug 24, 2022 | FY2022 | P00001 | G | $0.00 | — |
| Jun 24, 2022 | FY2022 | 0 | — | $84,728.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.